Recruiting IgA Nephropathy Studies in Dakota Dunes
About IgA Nephropathy Clinical Trials in Dakota Dunes
IgA nephropathy is the most common form of glomerulonephritis worldwide, caused by deposits of immunoglobulin A in the kidneys. It can lead to kidney inflammation and progressive kidney damage. Treatment includes blood pressure management, immunosuppression, and newer targeted therapies.
There are currently 2 iga nephropathy clinical trials recruiting participants in Dakota Dunes, SD. These studies are seeking a combined 65 participants. Research is being sponsored by ADARx Pharmaceuticals, Inc., Biohaven Therapeutics Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
IgA Nephropathy Clinical Trials in Dakota Dunes — FAQ
Are there iga nephropathy clinical trials in Dakota Dunes?
Yes, there are 2 iga nephropathy clinical trials currently recruiting in Dakota Dunes, SD. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Dakota Dunes?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dakota Dunes research site will contact you about next steps.
Are clinical trials in Dakota Dunes free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dakota Dunes studies also compensate for your time and travel.
What iga nephropathy treatments are being tested?
The 2 active trials in Dakota Dunes are testing new therapies including novel drugs, biologics, and treatment approaches for iga nephropathy.
Data updated July 13, 2026 from ClinicalTrials.gov